Home Healthcare Pharmaceuticals Hemophilia Gene Therapy Market

Hemophilia Gene Therapy Market Size, Share & Trends Analysis Report By Product (Hemgenix, Beqvez), By Type (Hemophilia A, Hemophilia B), By End User (Hospitals, Specialty Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Hemophilia Gene Therapy Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Hemgenix
    2. Beqvez
  2. Hemophilia Gene Therapy Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Hemophilia A
    2. Hemophilia B
  3. Hemophilia Gene Therapy Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Specialty Centers
    3. Others
  4. Regional Hemophilia Gene Therapy Market
    1. North America
      1. North America Hemophilia Gene Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Hemgenix
        2. Beqvez
      2. North America Hemophilia Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hemophilia A
        2. Hemophilia B
      3. North America Hemophilia Gene Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Centers
        3. Others
      4. U.S.
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      5. Canada
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
    2. Europe
      1. Europe Hemophilia Gene Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Hemgenix
        2. Beqvez
      2. Europe Hemophilia Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hemophilia A
        2. Hemophilia B
      3. Europe Hemophilia Gene Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Centers
        3. Others
      4. U.K.
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      5. Germany
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      6. France
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      7. Spain
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      8. Italy
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      9. Russia
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      10. Nordic
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      11. Benelux
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      12. Rest of Europe
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
    3. APAC
      1. APAC Hemophilia Gene Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Hemgenix
        2. Beqvez
      2. APAC Hemophilia Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hemophilia A
        2. Hemophilia B
      3. APAC Hemophilia Gene Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Centers
        3. Others
      4. China
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      5. Korea
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      6. Japan
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      7. India
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      8. Australia
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      9. Taiwan
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      10. South East Asia
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      11. Rest of Asia-Pacific
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
    4. Middle East and Africa
      1. Middle East and Africa Hemophilia Gene Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Hemgenix
        2. Beqvez
      2. Middle East and Africa Hemophilia Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hemophilia A
        2. Hemophilia B
      3. Middle East and Africa Hemophilia Gene Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Centers
        3. Others
      4. UAE
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      5. Turkey
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      6. Saudi Arabia
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      7. South Africa
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      8. Egypt
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      9. Nigeria
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      10. Rest of MEA
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
    5. LATAM
      1. LATAM Hemophilia Gene Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Hemgenix
        2. Beqvez
      2. LATAM Hemophilia Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Hemophilia A
        2. Hemophilia B
      3. LATAM Hemophilia Gene Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Centers
        3. Others
      4. Brazil
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      5. Mexico
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      6. Argentina
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      7. Chile
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      8. Colombia
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
      9. Rest of LATAM
        1. Hemgenix
        2. Beqvez
        3. Hemophilia A
        4. Hemophilia B
        5. Hospitals
        6. Specialty Centers
        7. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.